ChiCTR2400094546 版本V1.0 版本创建时间2024/12/24 15:58:32 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400094546 

最近更新日期:

Date of Last Refreshed on:

2024-12-24 15:58:09 

注册时间:

Date of Registration:

2024-12-24 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

慢性失眠障碍和肠道菌群的相互关系研究

Public title:

Research on the Interplay between Chronic Insomnia Disorder and Intestinal Microbiota

注册题目简写:

English Acronym:

研究课题的正式科学名称:

慢性失眠障碍和肠道菌群的相互关系研究

Scientific title:

Research on the Interplay between Chronic Insomnia Disorder and Intestinal Microbiota

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

于晶 

研究负责人:

于晶 

Applicant:

Jing Yu 

Study leader:

Jing Yu 

申请注册联系人电话:

Applicant telephone:

+86 159 0426 9767

研究负责人电话:

Study leader's
telephone:

+86 159 0426 9767

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15904269767@163.com

研究负责人电子邮件:

Study leader's E-mail:

15904269767@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

大连市甘井子区凌水路179号

研究负责人通讯地址:

大连市甘井子区凌水路179号

Applicant address:

No. 179 Lingshui Road, Ganjingzi District, Dalian

Study leader's address:

No. 179 Lingshui Road, Ganjingzi District, Dalian

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

大连市第七人民医院

Applicant's institution:

Dalian Seventh People's Hospital

研究负责人所在单位:

大连市第七人民医院

Affiliation of the Leader:

Dalian Seventh People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020-07

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

大连市第七人民医院伦理委员会

Name of the ethic committee:

Dalian Seventh People's Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2020-10-20 00:00:00

伦理委员会联系人:

管琳

Contact Name of the ethic committee:

Lin Guan

伦理委员会联系地址:

大连市甘井子区凌水路179号

Contact Address of the ethic committee:

No. 179 Lingshui Road, Ganjingzi District, Dalian

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 132 0409 0385

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

大连市第七人民医院

Primary sponsor:

Dalian Seventh People's Hospital

研究实施负责(组长)单位地址:

大连市甘井子区凌水路179号

Primary sponsor's address:

No. 179 Lingshui Road, Ganjingzi District, Dalian

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁

市(区县):

Country:

China

Province:

Liaoning

City:

单位(医院):

大连市第七人民医院

具体地址:

大连市甘井子区凌水路179号

Institution
hospital:

Dalian Seventh People's Hospital

Address:

No. 179 Lingshui Road, Ganjingzi District, Dalian

经费或物资来源:

财政拨款

Source(s) of funding:

financial allocation

研究疾病:

睡眠障碍  

Target disease:

sleep disorders

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

明确慢性失眠障碍和肠道菌群有无相关性,通过肠道菌群改变能否改变失眠障碍。  

Objectives of Study:

Clarify whether there is a correlation between chronic insomnia and gut microbiota, and whether changes in gut microbiota can alter insomnia disorders.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

血常规及心、肝、肾功能正常;文化程度小学及小学以上,理解程度好,能够配合顺利完成研究;取得患者对本研究的知情同意。 病例组:经匹兹堡睡眠质量指数量表(PSQI)初步筛选,且符合国际睡眠障碍(ICSD-3)中慢性睡眠障碍的诊断标准。 对照组:健康体检者。

Inclusion criteria

Normal blood routine and heart, liver, and kidney function; Education level of primary school or above, good understanding, able to cooperate and successfully complete research; Obtain informed consent from patients for this study. Case group: Preliminary screening by Pittsburgh Sleep Quality Index (PSQI) and meeting the diagnostic criteria for chronic sleep disorders in International Sleep Disorders (ICSD-3). Control group: Healthy individuals undergoing physical examinations.

排除标准:

a、无脑器质性疾病、精神分裂症、物质依赖及成瘾、心境障碍、冠心病、高血压、糖尿病、肝脏疾病、代谢性疾病、肥胖等病史。 b、三个月内使用过精神科药物、抗生素、肠道解痉剂及其他影响肠道菌群药物者。 c、妊娠期和哺乳期妇女; d、特殊饮食者。

Exclusion criteria:

No history of brain organic disease, schizophrenia, substance dependence and addiction, mood disorder, coronary heart disease, hypertension, diabetes, liver disease, metabolic disease, obesity, etc.; Individuals who have used psychiatric drugs, antibiotics, intestinal antispasmodics, and other drugs that affect gut microbiota within the past three months; pregnant and lactating women; special diet.

研究实施时间:

Study execute time:

From 2020-11-01 00:00:00 To 2022-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-25 00:00:00 To 2022-12-01 00:00:00

干预措施:

Interventions:

组别:

病例组

样本量:

30

Group:

Case group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

健康对照组

样本量:

30

Group:

Healthy control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning

City:

单位(医院):

大连市第七人民医院 

单位级别:

三甲 

Institution
hospital:

Dalian Seventh People’s Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肠道菌群

指标类型:

主要指标

Outcome:

Intestinal Microbiota

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数量表

指标类型:

主要指标

Outcome:

PSQI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

Stool

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

发表文章后;邮件联系

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After publishing the paper; Contact by email

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

None

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-12-24 15:58:09